^

Original-Research: Vidac Pharma Holding Plc - from Sphene Capital GmbH

29.07.2024 / 12:26 CET/CEST

Dissemination of a Research, transmitted by EQS News - a service of EQS

Group AG.

The issuer is solely responsible for the content of this research. The

result of this research does not constitute investment advice or an

invitation to conclude certain stock exchange transactions.

---------------------------------------------------------------------------

Classification of Sphene Capital GmbH to Vidac Pharma Holding Plc

Company Name: Vidac Pharma Holding Plc

ISIN: GB00BM9XQ619

Reason for the research: Update Report

Recommendation: Buy

from: 29.07.2024

Target price: EUR 4.90 (unchanged)

Target price on sight of: 36 months

Last rating change: -

Analyst: Peter Thilo Hasler

Promising results of a VDA-1275 study

Vidac Pharma published promising results of its study with the active

ingredient VDA-1275 in multiple mouse cancer and human cellular organoid

models of solid tumours in a paper submitted to peer-review. The study shows

that VDA-1275-which is being developed by Vidac Pharma as a systemic drug

for the treatment of solid tumours-exhibited statistically significant

efficacy as a monotherapy and synergistic effects in combination with two

standard cancer therapies and also elicited an immunological response. We

thereby confirm our Buy rating and our three-stage discounted cash flow

entity model based price target of EUR 4.90 (base case scenario), which is

based on the assumption that Vidac Pharma will get approval for its current

core product VDA-1102-AK. Monte Carlo scenario values range between EUR 4.04

(10% quantile) and EUR 5.40 (90% quantile) per share.

You can download the research here: http://www.more-ir.de/d/30305.pdf

Contact for questions:

Peter Thilo Hasler, CEFA

+49 (152) 31764553

---------------------------------------------------------------------------

The EQS Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---------------------------------------------------------------------------

1956187 29.07.2024 CET/CEST

°